Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-06-18

In mitochondrial disease respiratory complex III2 assembles complex I via toxic intermediate

Ayala-Hernandez, M. G., Torales, A. B., Tan, H. C., Montgomery, C. B., Padavannil, A., Cortopassi, G., Letts, J. A.

University of California DavisUniversity of California Davis · biorxiv

Abstract

Mutations in mitochondrial complex I can cause severe metabolic disease. Although no treatments are available for complex I deficiencies, chronic hypoxia improves lifespan and function in a mouse model of the severe mitochondrial disease Leigh syndrome caused by mutation of complex I subunit NDUFS4. To understand the molecular mechanism of NDUFS4 mutant pathophysiology and hypoxia rescue, we investigated the structure of complex I in respiratory supercomplexes isolated from NDUFS4 mutant mice. We identified complex I assembly intermediates bound to complex III2, proving the cooperative assembly model. Further, an accumulated complex I intermediate is structurally consistent with pathological oxygen-dependent reverse electron transfer, revealing unanticipated pathophysiology and hypoxia rescue mechanisms. Thus, the build-up of toxic intermediates and not simply decreases in complex I levels underlie mitochondrial disease.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that the accumulation of toxic intermediates, rather than simply decreased complex I levels, underlies mitochondrial disease pathophysiology. This research is relevant as it explores the molecular mechanisms of mitochondrial dysfunction, which is a significant contributor to aging and age-related diseases, potentially leading to insights that could inform longevity interventions.

Author of this paper? Send a correction.